BRIEF-Merit Medical Provides Update On US Reimbursement And Commercial Strategies For Wrapsody Cell-Impermeable Endoprosthesis

Reuters11-14

Nov 13 (Reuters) - Merit Medical Systems Inc MMSI.O:

MERIT MEDICAL PROVIDES UPDATE ON U.S. REIMBURSEMENT AND COMMERCIAL STRATEGIES FOR WRAPSODY® CELL-IMPERMEABLE ENDOPROSTHESIS
MERIT MEDICAL SYSTEMS INC - CMS DEFERS WRAPSODY CIE APPLICATION TO 2027 OUTPATIENT PROSPECTIVE PAYMENT SYSTEM RULE
MERIT MEDICAL SYSTEMS INC - FORECASTS $2 MILLION-$4 MILLION U.S. REVENUE FROM WRAPSODY CIE IN 2025

Source text: ID:nGNX6QJv0f

Further company coverage: MMSI.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2583351256?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 05:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583351256","market":"us","top_or_hot":-1,"title":"BRIEF-Merit Medical Provides Update On US Reimbursement And Commercial Strategies For Wrapsody Cell-Impermeable Endoprosthesis","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Merit Medical Provides Update On US Reimbursement And Commercial Strategies For Wrapsody Cell-Impermeable Endoprosthesis</title></head><body><p><span>Nov 13 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/MMSI\">Merit Medical Systems</a> Inc <span>MMSI.O</span>:</p><ul><li><p>MERIT MEDICAL PROVIDES UPDATE ON U.S. REIMBURSEMENT AND COMMERCIAL STRATEGIES FOR WRAPSODY® CELL-IMPERMEABLE ENDOPROSTHESIS</p></li><li><p>MERIT MEDICAL SYSTEMS INC - CMS DEFERS WRAPSODY CIE APPLICATION TO 2027 OUTPATIENT PROSPECTIVE PAYMENT SYSTEM RULE</p></li><li><p>MERIT MEDICAL SYSTEMS INC - FORECASTS $2 MILLION-$4 MILLION U.S. REVENUE FROM WRAPSODY CIE IN 2025</p></li></ul><p>Source text: <span>ID:nGNX6QJv0f</span></p><p>Further company coverage: <span>MMSI.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Merit Medical Provides Update On US Reimbursement And Commercial Strategies For Wrapsody Cell-Impermeable Endoprosthesis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Merit Medical Provides Update On US Reimbursement And Commercial Strategies For Wrapsody Cell-Impermeable Endoprosthesis\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-14 05:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Merit Medical Provides Update On US Reimbursement And Commercial Strategies For Wrapsody Cell-Impermeable Endoprosthesis</title></head><body><p><span>Nov 13 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/MMSI\">Merit Medical Systems</a> Inc <span>MMSI.O</span>:</p><ul><li><p>MERIT MEDICAL PROVIDES UPDATE ON U.S. REIMBURSEMENT AND COMMERCIAL STRATEGIES FOR WRAPSODY® CELL-IMPERMEABLE ENDOPROSTHESIS</p></li><li><p>MERIT MEDICAL SYSTEMS INC - CMS DEFERS WRAPSODY CIE APPLICATION TO 2027 OUTPATIENT PROSPECTIVE PAYMENT SYSTEM RULE</p></li><li><p>MERIT MEDICAL SYSTEMS INC - FORECASTS $2 MILLION-$4 MILLION U.S. REVENUE FROM WRAPSODY CIE IN 2025</p></li></ul><p>Source text: <span>ID:nGNX6QJv0f</span></p><p>Further company coverage: <span>MMSI.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1559883803.SGD","symbol_name":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUAMGKKM:1","article_id":"2583351256","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583351256","pubTimestamp":1763068844,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Merit Medical Provides Update On US Reimbursement And Commercial Strategies For Wrapsody Cell-Impermeable EndoprosthesisNov 13 (Reuters) - Merit Medical Systems Inc MMSI.O:MERIT MEDICAL PROVIDES","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","LU0566484027.USD":"安本美国小盘成长股","BK4198":"医疗保健用品","MMSI":"Merit Medical Systems"},"translate_title":"BRIEF-Merit Medical提供Wrapsody细胞不可渗透内用假体在美国报销和商业策略的最新信息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MMSI":0.9},"content_text":"BRIEF-Merit Medical Provides Update On US Reimbursement And Commercial Strategies For Wrapsody Cell-Impermeable EndoprosthesisNov 13 (Reuters) - Merit Medical Systems Inc MMSI.O:MERIT MEDICAL PROVIDES UPDATE ON U.S. REIMBURSEMENT AND COMMERCIAL STRATEGIES FOR WRAPSODY® CELL-IMPERMEABLE ENDOPROSTHESISMERIT MEDICAL SYSTEMS INC - CMS DEFERS WRAPSODY CIE APPLICATION TO 2027 OUTPATIENT PROSPECTIVE PAYMENT SYSTEM RULEMERIT MEDICAL SYSTEMS INC - FORECASTS $2 MILLION-$4 MILLION U.S. REVENUE FROM WRAPSODY CIE IN 2025Source text: ID:nGNX6QJv0fFurther company coverage: MMSI.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583351256","isCrawlerRequest":true}